Stocks · Health care · Pharmaceutical Preparations

Akebia Therapeutics, Inc.

AKBA Clue Score38

United States Fiscal year ends December CIK 0001517022 Results filed 5 Nov 2026

Add to watchlist

What the insiders did Net buying

Bought (120 mo)

$15.60M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$4.57M

$1.93M on a plan · $60.15K straight out of an exercise

Sold at will

$2.57M

96 of 127 sales

Net

+$11.03M

+$13.03M against sales at will